Watchmaker Genomics has collaborated with Revvity to automate its DNA and RNA library preparation kits for NGS workflows on the Sciclone™ G3 NGSx platform.

Amsbio has launched a new range of 96-well Deubiquitinating (DUB) enzyme assay kits for high-throughput screening. The kits are designed to measure DUB enzyme activity and screen inhibitors in cell-based models and purified enzyme systems.

ProBioGen’s GlymaxX technology supports the FDA-approved Ziihera® antibody for HER2-positive biliary tract cancer, advancing targeted therapies.

Atelerix partners with MineBio to bring its pioneering hydrogel-based cell preservation technology to China, enhancing biotech logistics and reducing costs.

Thermo Fisher Scientific has launched the 5L DynaDrive Single-Use Bioreactor, expanding their bioreactor portfolio. This bioreactor offers seamless scalability from 1 to 5,000 liters, enhancing productivity by 27% compared to glass bioreactors.

Sphere Bio expands its APAC distributor network, enhancing access to single-cell analysis technologies in key Asian and Pacific markets.

Scale Biosciences, Inc. (Scale Bio), announced its participation in the Chan Zuckerberg Initiative's (CZI) Billion Cells Project at the Chan Zuckerberg Biohub New York Affiliate Symposium.

Ultima Genomics has launched the "Count on Us" initiative, offering 3 trillion DNA sequencing reads to researchers at academic, public or non-profit institutions in the U.S. and Canada.

Thermo Fisher Scientific introduces new centrifuge models featuring GreenCool Technology. These floor-model centrifuges utilize natural refrigerants compliant with EU and EPA regulations.

Thermo Fisher Scientific and the Chan Zuckerberg Imaging Institute have announced a partnership to develop new technologies that enhance cryo-electron microscopy (cryo-EM).